Announcements Trials
Browse Landscape

Phase

Phase 1 22Phase 2 20Phase 3 4Phase NA 3Phase 1/2 3Phase 2/3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Recurrence 1Pancreatic Neoplasms 1Oligometastatic Lung Adenocarcinoma 1Neoplasm Metastasis 1NSCLC 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Carcinoma 1Breast Neoplasms 1

Interventions

Exercise 83Standard of Care 45Blood Specimen Collection 43Methods 32Therapeutics 28Surveys and Questionnaires 27Educational Status 25Control Groups 20Cognitive Behavioral Therapy 20Interviews as Topic 18Music Therapy 15Biopsy 15Acupuncture Therapy 15Palliative Care 14Resistance Training 13Magnetic Resonance Spectroscopy 13Early Intervention, Educational 13Radiotherapy 10Radiosurgery 10Nutrition Assessment 9Behavior Therapy 9Yoga 8Psychiatric Rehabilitation 8Practice Guidelines as Topic 8Patient Navigation 8Counseling 8Ultraviolet Therapy 7Physical Therapy Modalities 7Nutritional Status 7Mindfulness 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Neoplasms × Erlotinib Hydrochloride × Clear all
NCT01636908 2021-04-15

ICK

Amsterdam UMC, location VUmc

Phase NA Completed
43 enrolled
Tumor-Agnostic

Neoplasms

NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Amsterdam UMC, location VUmc

Phase NA Unknown
15 enrolled
CNS

Glioma, Neoplasms

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown
20 enrolled

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡